Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Merck KGaA's Enterprise Value is CHF66,015 Mil.
Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF3,374 Mil. Therefore, Merck KGaA's EV-to-EBIT ratio for today is 19.57.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Merck KGaA's Enterprise Value is CHF66,015 Mil.
Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was CHF5,532 Mil. Therefore, Merck KGaA's EV-to-EBITDA ratio for today is 11.93.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Merck KGaA's Enterprise Value is CHF66,015 Mil.
Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was CHF19,469 Mil. Therefore, Merck KGaA's EV-to-Revenue ratio for today is 3.39.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Merck KGaA's Enterprise Value is CHF66,015 Mil.
Merck KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF2,063 Mil. Therefore, Merck KGaA's EV-to-FCF ratio for today is 32.01.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Merck KGaA (XSWX:MER) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Merck KGaA's current Enterprise Value is CHF66,015 Mil.
Merck KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3,374 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Merck KGaA's current Enterprise Value is CHF66,015 Mil.
Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF5,532 Mil.
Merck KGaA's current Enterprise Value is CHF66,015 Mil.
Merck KGaA's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF19,469 Mil.
Merck KGaA's current Enterprise Value is CHF66,015 Mil.
Merck KGaA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF3,899 Mil.
Merck KGaA's current Enterprise Value is CHF66,015 Mil.
Merck KGaA's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2,063 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA Enterprise Value Related Terms
Merck KGaA Enterprise Value Historical Data
* Premium members only.
The historical data trend for Merck KGaA's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MER vs ZTS, UTHR, VTRS: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck KGaA Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Merck KGaA's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Merck KGaA's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of CHF66,015 Mil mean?
Merck KGaA (XSWX:MER) has a Enterprise Value of CHF66,015 Mil as of Jun. 29, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Merck KGaA and its competitors.
Is Merck KGaA's Enterprise Value too high?
Merck KGaA's current Enterprise Value is CHF66,015 Mil. Overall, Merck KGaA has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Enterprise Value compare to ZTS and UTHR?
Merck KGaA's Enterprise Value of CHF66,015 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Merck KGaA and its competitors. Merck KGaA's current Enterprise Value is CHF66,015 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (XSWX:MER) has a current Enterprise Value of CHF66,015 Mil. The stock's GF Value™ is CHF125.76, compared to a current price of CHF130.30 — trading 3.6% above its estimated fair value. The current Enterprise Value is CHF66,015 Mil. Merck KGaA's overall GF Score™ is 83/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Enterprise Value is CHF66,015 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck KGaA (XSWX:MER) Overvalued in 2026?
Based on GuruFocus' analysis, Merck KGaA stock appears to be overvalued.
The current stock price of CHF130.30 is trading 3.6% above its estimated GF Value™ of CHF125.76.
Key valuation signals for XSWX:MER:
Enterprise Value: CHF66,015 Mil
GF Value™: CHF125.76 vs. price of CHF130.30 (3.6% above fair value)
No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
83GF Score
Get the complete analysis for XSWX:MER
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MER has been successfully added to your 
